热门资讯> 正文
Achieve Life Sciences通过新的首席运营官加强领导团队
2025-09-18 23:46
- Achieve Life Sciences (NASDAQ:ACHV) promoted Craig Donnelly to COO.
- Mr. Donnelly will lead the supply chain and manufacturing activities with the commercial strategy ahead of a product launch in mid-late 2026.
- With more than 25 years of biopharmaceutical industry experience, Mr. Donnelly has expertise in both technical development and regulatory CMC at all stages of development.
- Mr. Donnelly previously held senior roles in CMC and regulatory functions at companies including NuCana, ICON (formerly Mapi), and F. Hoffman-La Roche.
More on Achieve Life Sciences
- Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript
- Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation
- Achieve Life Sciences gets new interim chief medical officer
- Achieve Life Sciences' nicotine dependence treatment under FDA review
- Seeking Alpha’s Quant Rating on Achieve Life Sciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
